Delivery Order SPE2DB22D3501-SPE2DB25FVJ30

Award Date 4/21/25
Potential Completion Date 5/12/25
Potential Value $30K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TERLIVAZ 0.85 MG VIALS, a pharmaceutical product, with a ceiling value of $2,462.36. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 9, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,824.39, is for the delivery of 4566262118 - TERLIVAZ 0.85 MG VIALS. The contract is a firm fixed-price delivery order with a period of performance through November 20, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a for-profit organization and is...
This federal contract award, valued at $6,081.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TERLIVAZ 0.85 MG VIALS, a pharmaceutical product. This is a firm fixed-price delivery order contract with a period of performance through July 22, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,584.58, is for the delivery of 4,567,873,999 units of the medication TRODELVY 180 MG VIALS. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 1, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRODELVY 180 MG VIALS, a pharmaceutical product. The contract has a firm fixed price, a ceiling value of $9,584.58, and a performance period ending on May 14, 2025. This contract is not a set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of medical vials. The contract has a ceiling value of $1,624.00 and a period of performance ending on September 13, 2024. This contract is not set aside for any specific business type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRODELVY 180 MG VIALS. The contract has a firm fixed price of $9,584.58 and a completion date of May 12, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,779.44 firm fixed-price contract is for the supply of TRODELVY 180 MG VIALS, a specialty medication. The contract has an ultimate completion date of March 4, 2025 and was awarded on February 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $53,720.08, is for the delivery of TALVEY 40 MG/ML VIALML pharmaceutical products. It is a firm fixed-price contract with an ultimate completion date of August 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,824.28, is for the delivery of the specialty medication TECVAYLI 153 MG/1.7 ML VIAL 1.7ML. The contract has a firm fixed price pricing type and an ultimate completion date of November 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FVJ30
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TERLIVAZ 0.85 MG VIALS, a pharmaceutical product, with a ceiling value of $29,548.32 and a performance period through May 12, 2025. The contract is a firm fixed-price delivery order, which is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, that provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is likely part of the company's broader support for federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 7/21/25, 7:44 PM